Evoke Pharma (EVOK) Tops Q2 EPS by 4c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• Tesla to launch Cybercab in Austin this month - report